KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Capital Expenditures: 2009-2024

Historic Capital Expenditures for Arbutus Biopharma (ABUS) over the last 16 years, with Dec 2024 value amounting to $182,000.

  • Arbutus Biopharma's Capital Expenditures was N/A to $86,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $214,000, marking a year-over-year change of. This contributed to the annual value of $182,000 for FY2024, which is 81.94% down from last year.
  • Arbutus Biopharma's Capital Expenditures amounted to $182,000 in FY2024, which was down 81.94% from $1.0 million recorded in FY2023.
  • Arbutus Biopharma's 5-year Capital Expenditures high stood at $1.0 million for FY2023, and its period low was $182,000 during FY2024.
  • For the 3-year period, Arbutus Biopharma's Capital Expenditures averaged around $567,333, with its median value being $512,000 (2022).
  • In the last 5 years, Arbutus Biopharma's Capital Expenditures soared by 253.28% in 2021 and then plummeted by 81.94% in 2024.
  • Arbutus Biopharma's Capital Expenditures (Yearly) stood at $229,000 in 2020, then surged by 253.28% to $809,000 in 2021, then tumbled by 36.71% to $512,000 in 2022, then soared by 96.88% to $1.0 million in 2023, then tumbled by 81.94% to $182,000 in 2024.